Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
Die Pharmazie
|
October 1, 1993
Conventional versus novel conditions for the in vitro dissolution testing of parenteral slow release formulations: application to doxepin parenteral dosage forms
C Gido, P Langguth, J Kreuter, et al.
Clinical Pharmacology and Therapeutics
|
July 22, 2011
Bioequivalence of oral products and the biopharmaceutics classification system: science, regulation, and public policy
K S Amidon, P Langguth, H Lennernäs, et al.
Peptides
|
January 1, 1996
Enzymatic cleavage of thymopoietin oligopeptides by pancreatic and intestinal brush-border enzymes
J Heizmann, P Langguth, A Biber, et al.
Pharmaceutical Research
|
April 1, 1996
Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo
U Wetterich, H Spahn-Langguth, E Mutschler, et al.
Die Pharmazie
|
December 1, 2023
Delivery of free amino acids into and through the stratum corneum of the skin using micro emulsions and microemulsion-based hydrogels: Formulation, characterization, and ex-<i>vivo</i> permeation studies
B N Kahsay, S L Meiser, J Wohlrab, et al.
British Journal of Clinical Pharmacology
|
October 1, 1993
The pharmacokinetics of tranylcypromine enantiomers in healthy subjects after oral administration of racemic drug and the single enantiomers
H Weber-Grandke, G Hahn, E Mutschler, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1995
Gastrointestinal absorption of peptide drug: quantitative evaluation of the degradation and the permeation of metkephamid in rat small intestine
Y Taki, T Sakane, T Nadai, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 23, 1998
Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay
S Döppenschmitt, P Langguth, C G Regårdh, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
June 1, 1995
Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogs
E Lipka, I D Lee, P Langguth, et al.
Journal of Pharmaceutical Sciences
|
February 9, 2000
Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport
C Hilgendorf, H Spahn-Langguth, C G Regårdh, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
Die Pharmazie
|
October 1, 1993
Conventional versus novel conditions for the in vitro dissolution testing of parenteral slow release formulations: application to doxepin parenteral dosage forms
C Gido, P Langguth, J Kreuter, et al.
Clinical Pharmacology and Therapeutics
|
July 22, 2011
Bioequivalence of oral products and the biopharmaceutics classification system: science, regulation, and public policy
K S Amidon, P Langguth, H Lennernäs, et al.
Peptides
|
January 1, 1996
Enzymatic cleavage of thymopoietin oligopeptides by pancreatic and intestinal brush-border enzymes
J Heizmann, P Langguth, A Biber, et al.
Pharmaceutical Research
|
April 1, 1996
Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo
U Wetterich, H Spahn-Langguth, E Mutschler, et al.
Die Pharmazie
|
December 1, 2023
Delivery of free amino acids into and through the stratum corneum of the skin using micro emulsions and microemulsion-based hydrogels: Formulation, characterization, and ex-<i>vivo</i> permeation studies
B N Kahsay, S L Meiser, J Wohlrab, et al.
British Journal of Clinical Pharmacology
|
October 1, 1993
The pharmacokinetics of tranylcypromine enantiomers in healthy subjects after oral administration of racemic drug and the single enantiomers
H Weber-Grandke, G Hahn, E Mutschler, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1995
Gastrointestinal absorption of peptide drug: quantitative evaluation of the degradation and the permeation of metkephamid in rat small intestine
Y Taki, T Sakane, T Nadai, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 23, 1998
Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay
S Döppenschmitt, P Langguth, C G Regårdh, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
June 1, 1995
Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogs
E Lipka, I D Lee, P Langguth, et al.
Journal of Pharmaceutical Sciences
|
February 9, 2000
Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport
C Hilgendorf, H Spahn-Langguth, C G Regårdh, et al.
Page
of 8